{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:33:58Z","timestamp":1780522438215,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jpeds.2014.12.014","type":"journal-article","created":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T23:03:13Z","timestamp":1421362993000},"page":"992-997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Adverse Events following Haemophilus influenzae Type b Vaccines in the Vaccine Adverse Event Reporting System, 1990-2013"],"prefix":"10.1016","volume":"166","author":[{"given":"Pedro L.","family":"Moro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Jankosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5647-0779","authenticated-orcid":false,"given":"David","family":"Menschik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3762-2108","authenticated-orcid":false,"given":"Brock","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom T.","family":"Shimabukuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2014.12.014_bib1","first-page":"296","article-title":"FDA approval of use of a new haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and haemophilus b conjugate vaccine for infants and children","volume":"42","author":"Centers for Disease Control and Prevention","year":"1993","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-01","key":"10.1016\/j.jpeds.2014.12.014_bib2","first-page":"1","article-title":"Prevention and control of haemophilus influenzae type b disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"63","author":"Briere","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jpeds.2014.12.014_bib3","first-page":"107","article-title":"FDA approval for infants of a Haemophilus influenzae type b conjugate and hepatitis B (recombinant) combined vaccine","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jpeds.2014.12.014_bib4","first-page":"1079","article-title":"Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jpeds.2014.12.014_bib5","first-page":"52","article-title":"Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) recommendations and rationale","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jpeds.2014.12.014_bib6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0022-3476(05)80424-X","article-title":"Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines","volume":"120","author":"Decker","year":"1992","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2014.12.014_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0022-3476(05)81786-X","article-title":"Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine","volume":"121","author":"Fritzell","year":"1992","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2014.12.014_bib8","first-page":"832","article-title":"Immunogenicity of Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine in infants","volume":"147","author":"Holmes","year":"1993","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jpeds.2014.12.014_bib9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0022-3476(05)83428-6","article-title":"Responses of children to booster immunization with their primary conjugate Haemophilus influenzae type B vaccine or with polyribosylribitol phosphate conjugated with diphtheria toxoid","volume":"122","author":"Decker","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2014.12.014_bib10","doi-asserted-by":"crossref","first-page":"e1375","DOI":"10.1542\/peds.2009-2992","article-title":"Immunogenicity and Safety of H. influenzae Type b-N meningitidis C\/Y conjugate vaccine in Infants","volume":"127","author":"Bryant","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2014.12.014_bib11","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1586\/14760584.4.6.793","article-title":"A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus, and Haemophilus influenzae type b vaccine","volume":"4","author":"Black","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jpeds.2014.12.014_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1542\/peds.2007-3317","article-title":"Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial","volume":"123","author":"Guerra","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2014.12.014_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/hv.18752","article-title":"The safety profile of Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine (HibMenCY)","volume":"8","author":"Rinderknecht","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jpeds.2014.12.014_bib14","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.vaccine.2003.06.001","article-title":"Post-marketing evaluation of the short term safety of Comvax (R)","volume":"22","author":"Davis","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2014.12.014_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/aje\/kws317","article-title":"Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study","volume":"177","author":"Nelson","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jpeds.2014.12.014_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2014.12.014_bib18","first-page":"52252","article-title":"21 CFR Part 600.80. Postmarketing reporting of adverse experiences","volume":"62","author":"Food and Drug Administration","year":"1997","journal-title":"Fed Regist"},{"key":"10.1016\/j.jpeds.2014.12.014_bib19","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1016\/j.vaccine.2010.09.021","article-title":"Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010","volume":"28","author":"Vellozzi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2014.12.014_bib20","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"R\u00fcggeberg","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2014.12.014_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","article-title":"Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system","volume":"53","author":"DuMouchel","year":"1999","journal-title":"Am Stat"},{"key":"10.1016\/j.jpeds.2014.12.014_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","article-title":"Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database","volume":"25","author":"Szarfman","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.jpeds.2014.12.014_bib23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40264-013-0051-9","article-title":"Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine","volume":"36","author":"Martin","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.jpeds.2014.12.014_bib24","series-title":"Rudolph\u2019s pediatrics","year":"2011"},{"key":"10.1016\/j.jpeds.2014.12.014_bib25","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.vaccine.2011.12.042","article-title":"Febrile seizures after 2010-2011 influenza vaccine in young children, United States: a vaccine safety signal from the vaccine adverse event reporting system","volume":"30","author":"Leroy","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2014.12.014_bib26","first-page":"1","article-title":"Deaths: final data for 2010","volume":"61","author":"Murphy","year":"2013","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.jpeds.2014.12.014_bib27","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1542\/peds.2005-1499","article-title":"The changing concept of sudden infant death syndrome: diagnostic coding shifts, controversies regarding the sleeping environment, and new variables to consider in reducing risk","volume":"116","author":"American Academy of Pediatrics Task Force on Sudden Infant Death Syndrome","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2014.12.014_bib28","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.jpeds.2014.12.014_bib29","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1016\/j.vaccine.2007.02.068","article-title":"Unexplained sudden death, including sudden infant death syndrome (SIDS), in the first and second years of life: case definition and guidelines for collection, analysis, and presentation of immunization safety data","volume":"25","author":"Jorch","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2014.12.014_bib30","series-title":"Immunization safety review: vaccinations and sudden unexpected death in infancy","author":"Institute of Medicine","year":"2003"},{"key":"10.1016\/j.jpeds.2014.12.014_bib31","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1016\/j.vaccine.2007.02.077","article-title":"Do immunisations reduce the risk for SIDS? A meta-analysis","volume":"25","author":"Vennemann","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2014.12.014_bib32","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.vaccine.2006.07.027","article-title":"Sudden infant death syndrome: no increased risk after immunisation","volume":"25","author":"Vennemann","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2014.12.014_bib33","doi-asserted-by":"crossref","first-page":"e643","DOI":"10.1542\/peds.2004-2185","article-title":"Probability of coincident vaccination in the 24 or 48 hours preceding sudden infant death syndrome death in Australia","volume":"115","author":"Brotherton","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2014.12.014_bib34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/pds.619","article-title":"The epidemiology of fatalities reported to the vaccine adverse event reporting system 1990-1997","volume":"10","author":"Silvers","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jpeds.2014.12.014_bib35","doi-asserted-by":"crossref","first-page":"E51","DOI":"10.1542\/peds.106.4.e51","article-title":"Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years\u2019 data from the Vaccine Adverse Event Reporting System (VAERS)","volume":"106","author":"Braun","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2014.12.014_bib36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1311738","article-title":"Risk of intussusception after monovalent rotavirus vaccination","volume":"370","author":"Weintraub","year":"2014","journal-title":"N Engl J Med"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347614011639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347614011639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T16:02:32Z","timestamp":1717689752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347614011639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0022347614011639"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2014.12.014","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse Events following Haemophilus influenzae Type b Vaccines in the Vaccine Adverse Event Reporting System, 1990-2013","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2014.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}